UPDATED - Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
MWN-AI** Summary
Clover Health Investments, Corp. (Nasdaq: CLOV) has announced an important advancement in its partnership with Kno2, launching a live platform that enhances data interoperability in line with recent federal initiatives from the Centers for Medicare & Medicaid Services (CMS). The updated collaboration marks a significant move towards realizing seamless data exchange for Medicare patients, demonstrating that timely access to healthcare information is achievable now.
Employing standardized FHIR (USCDI v3) formats, Clover Health enables real-time responses to patient requests for clinical and claims data. This initiative aligns with CMS’s efforts to create an interconnected healthcare ecosystem, allowing patients to easily manage and share their health data across various care settings, especially vital for those with chronic conditions who navigate multiple healthcare avenues.
Clover’s technological backbone, powered by Counterpart Health, supports an extensive integration of clinical data, ensuring smooth communication among providers and enhancing value-based care. The platform facilitates a bi-directional exchange of patient information, enabling Clover to efficiently respond as a payer with structured data. This capability not only enhances member experience by fostering transparency but also empowers patients by giving them control over their health journey.
During the HIMSS 2026 conference, Clover Health and its partners will demonstrate this streamlined patient data workflow, showcasing how requests flow through Kno2’s network, allowing quick access to essential health information from Clover’s infrastructure. This collaboration not only sets a new standard for payer practices but highlights Clover’s commitment to improving healthcare access for Medicare recipients by leveraging cutting-edge technology and participating actively in national interoperability initiatives.
Overall, Clover Health, along with Counterpart Health and Kno2, is taking significant steps toward transforming healthcare communication and improving patient outcomes through innovative technology.
MWN-AI** Analysis
Clover Health Investments, Corp. (Nasdaq: CLOV) has made significant strides in aligning with federal interoperability initiatives, which could present a notable investment opportunity. The recent collaboration with Kno2 to enhance real-time access to clinical and claims data signifies Clover's commitment to improving healthcare delivery for Medicare patients.
In a healthcare landscape increasingly driven by data exchange and value-based care, Clover Health's transition from "Pledge to Production" highlights its readiness to operationalize interoperability. This is a pivotal moment as the Centers for Medicare & Medicaid Services (CMS) push for improved health information exchange among provider networks. By implementing standardized FHIR (Fast Healthcare Interoperability Resources) formats, Clover Health is positioning itself as a leader in this domain.
The company's strategy, fueled by its proprietary platform, Clover Assistant, allows for enhanced patient management and proactive care. This innovative approach not only aids in chronic disease management but also underscores the importance of delivering timely, actionable information to patients and care teams. As healthcare moves toward greater transparency and efficiency, firms that prioritize interoperability will likely experience increased demand for their services.
Moreover, Clover's dedication to operationalizing comprehensive data exchange is likely to resonate positively in the investor community, especially as it positions itself to benefit from the broader CMS-aligned network initiatives. Investors should watch for Clover's market performance at the HIMSS 2026 event, where live demonstrations will showcase these capabilities.
In summary, Clover Health represents a compelling opportunity for investors interested in the intersection of technology and healthcare. As the company continues to enhance its interoperable systems and respond effectively to market needs, it stands to capture significant market share in the Medicare space and beyond. However, investors should monitor developments closely, particularly around regulatory changes and competitive responses in the fast-evolving healthcare landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of Clover Health's participation in federal interoperability initiatives.
WILMINGTON, Del., March 10, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, and Kno2, healthcare’s leading communication network, today announced a collaboration enabling Clover Health to be live on a network that is participating in interoperability efforts publicly announced by the Centers for Medicare & Medicaid Services (CMS) to drive interoperability goals. Clover is demonstrating that nationwide, interoperable data exchange is not aspirational, it is achievable today.
Through this collaboration, Clover Health now responds in real time to patient-directed requests for clinical and claims data using standardized FHIR (USCDI v3) formats. This activity is consistent with publicly described CMS Health Tech Ecosystem, including the CMS-aligned network concepts and TEFCA’s IAS implementation, enabling patients to securely authenticate and request their health information from any participating payer through a connected network.
As patients move across care settings, seamless data exchange becomes critical. A Medicare patient with multiple chronic conditions may transition between primary care, specialty care, hospital, and home-based services. With standards-based interoperability, care teams remain aligned, enabling proactive, coordinated care within a value-based model.
Clover Health’s participation is powered by Counterpart Health, its technology and services business that enables physicians, payers, and risk-based entities to achieve outsized success in value-based care by leveraging a wide range of clean clinical data at scale. Kno2 securely routes patient-directed requests across the network and Counterpart Health enables the standardized exchange of data. Clover Health then responds as the payer with structured clinical and claims information.
Clover Health’s early participation reflects its support for broader national interoperability efforts and demonstrates how interoperable, patient-directed data exchange can operationalize today. Because the underlying infrastructure is powered by Counterpart Health, similar technical capabilities may be extended to other health plans seeking to participate in interoperability networks.
“Counterpart Assistant was built from the ground up as a bi-directional interoperable platform, already connecting hundreds of data sources. These are not bolt-on capabilities or compliance projects. They are foundational components of how the system operates in production,” said Kevin Holub, Chief Product Officer at Counterpart Health. “When that infrastructure already exists, participating in aligned networks becomes a fast add on benefit, not a build.”
"When our members have secure, real-time access to their clinical and claims information, it enables both transparency and control, including easier sharing with caregivers and providers, and ultimately a deeper understanding of their own health journey," said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “Because of Clover Assistant and the infrastructure we already have in place through Counterpart Health, we are well positioned to meet member needs like this today."
"Clover Health's willingness to enable real-time patient access to claims data, sets the standard for payers everywhere. We're proud to enable this milestone and look forward to expanding into broader interoperability initiatives as CMS and TEFCA have put forth." said Therasa Bell, President & Founder, Kno2.
Clover Health, Kno2, and Counterpart Health will conduct live demonstrations of an end-to-end response to a patient authenticated claims data request March 10 - 12, 2026 throughout HIMSS 2026 in the Aligned Networks Showcase at the Kno2 booth #12720. The demonstration will show a patient request flowing through the network via Kno2, reaching Counterpart Health’s responding gateway, and securely returning structured clinical and claims data from Clover Health’s infrastructure.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale.
Visit: www.cloverhealth.com
About Counterpart Health:
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on Diabetes, Chronic Kidney Disease, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease management, as well as Clinical Quality and Underserved Patient Populations.
About Kno2:
Kno2 is leading the future of healthcare communication by providing the nation’s largest comprehensive communication network including as a federally designated Qualified Health Information Network (QHIN) and CMS Aligned network. Kno2 enables secure, effortless exchange of patient information across providers, payers, patients, and technology vendors, processing billions of transactions annually.
Media Contacts:
Clover Health: press@cloverhealth.com
FAQ**
How does Clover Health Investments Corp. CLOV plan to leverage its partnership with Kno2 to enhance real-time data exchange for Medicare patients?
2. What specific federal interoperability initiatives is Clover Health Investments Corp. CLOV participating in, and how do they aim to improve patient care through these efforts?
3. Can you elaborate on how Clover Health Investments Corp. CLOV uses the Counterpart Assistant to support care teams in managing patients with chronic conditions?
4. What are the anticipated outcomes for members of Clover Health Investments Corp. CLOV as a result of their enhanced interoperability capabilities with Kno2?
**MWN-AI FAQ is based on asking OpenAI questions about Clover Health Investments Corp. (NASDAQ: CLOV).
NASDAQ: CLOV
CLOV Trading
4.66% G/L:
$2.04 Last:
1,735,310 Volume:
$2.03 Open:
